Search Results - "Monaghan, Laura"
-
1
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia
Published in Frontiers in oncology (02-08-2019)“…Growing evidence has demonstrated that epigenetic dysregulation is a common pathological feature in human cancer cells. Global alterations in the epigenetic…”
Get full text
Journal Article -
2
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival
Published in Cell death & disease (03-06-2021)“…Epigenomic dysregulation is a common pathological feature in human hematological malignancies. H3K9me3 emerges as an important epigenomic marker in acute…”
Get full text
Journal Article -
3
P433: PHARMACOLOGICAL DUAL INHIBITION OF PARP AND TIP60 AS A PROSPECTIVE THERAPEUTIC REGIMEN INDUCES SYNERGISTIC AML CELL DEATH
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
Patient Disposition and Clinical Outcome After Referral to a Dedicated TAVI Clinic
Published in Frontiers in cardiovascular medicine (10-01-2020)“…Transcatheter aortic valve implantation (TAVI) is the standard of care for the majority of patients with severe symptomatic aortic stenosis (AS) at excessive-,…”
Get full text
Journal Article -
5
Translation‐coupled mRNA quality control mechanisms
Published in The EMBO journal (04-10-2023)“…Abstract mRNA surveillance pathways are essential for accurate gene expression and to maintain translation homeostasis, ensuring the production of fully…”
Get full text
Journal Article -
6
Synergistic Leukaemia Cell Death Induced with PARP and TiP60 Inhibitors Is a Prospective Therapeutic Strategy for AML
Published in Blood (15-11-2022)Get full text
Journal Article -
7
Pharmacological Targeting of Kdm4a as a Potential Therapeutic Strategy in Aml
Published 01-01-2021Get full text
Dissertation -
8
Efficient Elimination of Acute Myeloid Leukemia Cells through Inhibition of KDM4A in Combination with PARP Inhibition
Published in Blood (13-11-2019)“…Epigenetic therapies are emerging as a promising therapeutic strategy for acute myeloid leukemia (AML), exemplified by advances in the development of…”
Get full text
Journal Article -
9
A molecular signature for delayed graft function
Published in Aging cell (01-10-2018)“…Chronic kidney disease and associated comorbidities (diabetes, cardiovascular diseases) manifest with an accelerated ageing phenotype, leading ultimately to…”
Get full text
Journal Article -
10
The Histone Demethylase KDM4A Is Required to Sustain H3K9me3/H3K27me3 Epigenetic States and Oncogenesis in MLL-AF9 Acute Myeloid Leukemia
Published in Blood (29-11-2018)“…Acute Myeloid Leukemia (AML) is an aggressive heterogeneous hematological malignancy. Persistence of leukemia stem cells (LSC) drive AML leukemogenesis,…”
Get full text
Journal Article -
11
α-Functional glycopolymers: New materials for (poly)peptide conjugation
Published in Polymer (Guilford) (08-09-2005)“…The synthesis and characterization of a number of N-(hydroxy)succinimidyl ester-terminated glycopolymers obtained via copper(I)-catalysed living radical…”
Get full text
Journal Article -
12
Rabbit-proof fence: Çit
Published 2006“…30'lı yıllarda yaşanmış gerçek bir olaydan yola çıkılarak gerçekleştirildi. 1931 yılında Avustralya yerlisi çocuklar ailelerinden koparılarak uzaklarda bir…”
Get more information
Video Recording -
13
a-functional glycopolymers: new materials for (poly)peptide conjugation
Published in Polymer (Guilford) (08-09-2005)“…The synthesis and characterization of a number of N-(hydroxy)succinimidyl ester-terminated glycopolymers obtained via copper(I)-catalysed living radical…”
Get full text
Journal Article -
14